Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

Profluent has raised $106 million to scale up use of its AI models for biology in drug development and agriculture.

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

David Baker, Nobel Prize laureate and UW biochemistry professor, detailed the design and applications of new proteins using ...

RBC Capital analyst Leonid Timashev upgraded Design Therapeutics (DSGN) to Outperform from Sector Perform with a price target of $13, up from $6.

A Seattle startup company has inked a deal with Eli Lilly to develop AI-powered cancer treatments. The team at Lila Biologics says they're pioneering the translation of AI design proteins for ...

In medicine and biotechnology, the ability to evolve proteins with new or improved functions is crucial, but current methods are often slow and laborious. Now, Scripps Research scientists have ...

A mini-peptide has been created that delays the early damage caused by Parkinson's disease and promises a way to slow down ...